DK1843754T3 - Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof - Google Patents
Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stofInfo
- Publication number
- DK1843754T3 DK1843754T3 DK06700941.5T DK06700941T DK1843754T3 DK 1843754 T3 DK1843754 T3 DK 1843754T3 DK 06700941 T DK06700941 T DK 06700941T DK 1843754 T3 DK1843754 T3 DK 1843754T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- composition containing
- candesartan cilexetil
- crystalline substance
- new pharmaceutical
- Prior art date
Links
- GHOSNRCGJFBJIB-UHFFFAOYSA-N Candesartan cilexetil Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C3=NNN=N3)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 GHOSNRCGJFBJIB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004349 candesartan cilexetil Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200500021 | 2005-01-26 | ||
| PCT/EP2006/000587 WO2006079496A1 (en) | 2005-01-26 | 2006-01-24 | New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1843754T3 true DK1843754T3 (da) | 2011-11-21 |
Family
ID=36035685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06700941.5T DK1843754T3 (da) | 2005-01-26 | 2006-01-24 | Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080118564A1 (da) |
| EP (1) | EP1843754B1 (da) |
| JP (1) | JP2008528456A (da) |
| AT (1) | ATE518526T1 (da) |
| DK (1) | DK1843754T3 (da) |
| ES (1) | ES2371145T3 (da) |
| PL (1) | PL1843754T3 (da) |
| SI (1) | SI1843754T1 (da) |
| WO (1) | WO2006079496A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5063370B2 (ja) * | 2005-06-27 | 2012-10-31 | 第一三共株式会社 | 湿式造粒製薬の調製方法 |
| TWI494134B (zh) * | 2006-06-20 | 2015-08-01 | Siegfried Generics Int Ag | 含有坎地沙坦酯的組成物、錠劑和顆粒及該錠劑的製造方法 |
| WO2008045006A1 (en) * | 2006-10-11 | 2008-04-17 | Fako Ilaclari A. S. | Formulations of candesartan |
| ES2301401B1 (es) * | 2006-11-28 | 2009-06-08 | Laboratorios Liconsa S.A. | Composicion farmaceutica solida estabilizada de candesartan cilexetilo. |
| SI2165702T1 (sl) | 2008-09-17 | 2012-05-31 | Helm Ag | Stabilni in z lahkoto raztopljeni sestavki kandesartan cileksetila pripravljeni z vlažno granulacijo |
| CN102415998A (zh) * | 2010-09-28 | 2012-04-18 | 扬子江药业集团北京海燕药业有限公司 | 盐酸马尼地平固体分散体及其制备方法 |
| JP2013224265A (ja) * | 2012-04-19 | 2013-10-31 | Asahi Kasei Chemicals Corp | 打圧感受性薬物を含有する錠剤 |
| EP2928468A4 (en) | 2012-12-05 | 2016-07-27 | Sawai Seiyaku Kk | CANDESARTANCILEXETILANEOUS PREPARATION |
| CN103006598B (zh) * | 2012-12-31 | 2015-12-02 | 广州白云山天心制药股份有限公司 | 含氯化钠药物载体的降血压片剂 |
| JP5651812B1 (ja) | 2013-04-25 | 2015-01-14 | 杏林製薬株式会社 | 固形医薬組成物 |
| JP5844929B1 (ja) * | 2015-04-03 | 2016-01-20 | 共和薬品工業株式会社 | カンデサルタンシレキセチル及びヒドロクロロチアジドを含む錠剤 |
| EP3219309A1 (en) * | 2016-03-17 | 2017-09-20 | K.H.S. Pharma Holding GmbH | Fixed dosed pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension |
| CN110876726A (zh) * | 2019-11-20 | 2020-03-13 | 白喜平 | 一种坎地沙坦酯制剂及其制备方法 |
| JPWO2022092183A1 (da) * | 2020-10-30 | 2022-05-05 | ||
| JP2023114946A (ja) * | 2022-02-07 | 2023-08-18 | 株式会社ファンケル | 錠剤、錠剤の崩壊性を改善する方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| TW284688B (da) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
| CA2577233C (en) * | 1996-04-05 | 2009-08-18 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition containing angiotensin ii antagonist |
| US6210710B1 (en) * | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
| ATE481090T1 (de) * | 1998-07-28 | 2010-10-15 | Takeda Pharmaceutical | Leicht zerfallende feste zubereitung |
| EE05670B1 (et) * | 1999-08-30 | 2013-08-15 | Aventis Pharma Deutschland Gmbh | Ramipriil kardiovaskulaarsete haigusjuhtude rahoidmiseks |
| DE10029201A1 (de) * | 2000-06-19 | 2001-12-20 | Basf Ag | Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung |
| WO2002030400A1 (fr) * | 2000-10-06 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Preparations solides |
| WO2003000169A1 (fr) * | 2001-06-20 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Procede de fabrication de comprimes |
| AUPS236902A0 (en) * | 2002-05-16 | 2002-06-13 | Northern Sydney Area Health Service | Composition and method for treating hypertension |
| US20040202730A1 (en) * | 2003-04-08 | 2004-10-14 | Robert Gow | Rosmarinic acid composition |
-
2006
- 2006-01-24 SI SI200631159T patent/SI1843754T1/sl unknown
- 2006-01-24 WO PCT/EP2006/000587 patent/WO2006079496A1/en not_active Ceased
- 2006-01-24 AT AT06700941T patent/ATE518526T1/de active
- 2006-01-24 EP EP06700941A patent/EP1843754B1/en not_active Not-in-force
- 2006-01-24 JP JP2007551631A patent/JP2008528456A/ja active Pending
- 2006-01-24 DK DK06700941.5T patent/DK1843754T3/da active
- 2006-01-24 PL PL06700941T patent/PL1843754T3/pl unknown
- 2006-01-24 ES ES06700941T patent/ES2371145T3/es active Active
- 2006-01-24 US US11/795,920 patent/US20080118564A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008528456A (ja) | 2008-07-31 |
| WO2006079496A1 (en) | 2006-08-03 |
| ATE518526T1 (de) | 2011-08-15 |
| US20080118564A1 (en) | 2008-05-22 |
| EP1843754A1 (en) | 2007-10-17 |
| EP1843754B1 (en) | 2011-08-03 |
| PL1843754T3 (pl) | 2011-12-30 |
| SI1843754T1 (sl) | 2011-12-30 |
| ES2371145T3 (es) | 2011-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1843754T3 (da) | Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof | |
| AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
| UA94942C2 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
| AR060536A1 (es) | Agonista del receptor de glucocorticoides y composiciones farmaceuticas | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| EP2130552A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE | |
| CO6612278A2 (es) | Composición acuosa antitranspirante/desodorante | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
| CR11441A (es) | Producto de dispersion solida que contiene un compuesto a base de n-aril urea | |
| EA201000089A1 (ru) | Применение гомо- и сополимеров для стабилизации составов активных ингредиентов | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| MY151295A (en) | Pyrimidyl indoline compound | |
| CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
| ECSP099442A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| MY151468A (en) | Controlled release solid preparation | |
| WO2009060952A1 (ja) | 新規製剤 | |
| CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. | |
| UA101407C2 (ru) | Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат | |
| PE20060771A1 (es) | Profarmaco de amida de gemcitabina y composiciones que lo contienen | |
| CL2009001267A1 (es) | Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis. | |
| FR2925331B1 (fr) | Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines | |
| ATE388695T1 (de) | Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose | |
| AR065597A1 (es) | Compuesto ester y su uso | |
| BRPI0815531A2 (pt) | "compostos, composição farmacêutica, composição cosmética, uso cosmético de uma composição e uso de um composto" |